UVE insider files to sell 20,000 shares
UVE-related filing reports a proposed sale of 20,000 common shares on 06/11/2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
UVE-related filing reports a proposed sale of 20,000 common shares on 06/11/2026. The filing lists the sale as Lieu Compensation to be effected for cash through Raymond James & Associates. The notice also lists three prior sales of 20,000 shares each on 03/25/2026, 04/29/2026, and 05/15/2026 with transaction proceeds shown.
Insights
Form 144 notifies a planned insider sale of 20,000 shares on 06/11/2026.
The notice identifies the sales method as cash disposition and the stated reason as Lieu Compensation. The excerpt lists broker details (Raymond James & Associates) and an aggregate transaction value for the 20,000 shares.
Past sales of 20,000 shares on 03/25/2026, 04/29/2026, and 05/15/2026 are shown with their proceeds; timing and routing imply routine planned dispositions. Cash‑flow treatment: proceeds payable to the selling holder as disclosed in the excerpt.
Key Figures
Key Terms
Form 144 regulatory
Lieu Compensation financial
Issuer regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the UVE Form 144 report?
Who is the broker and how is the sale described in the UVE filing?
What prior insider sales does the Form 144 show for UVE?
Will the company receive proceeds from this transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.